First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control
Phase 2 Study Results Highlight Use of Once-Daily Injection for Weight Loss and Reduction in Insulin Use NEW…
The Conference Board Leading Economic Index® (LEI) for the US Declined Again in September
NEW YORK, Dec. 9, 2025 /PRNewswire/ — The Conference Board Leading Economic Index® (LEI) for the US declined…